The Rough Guide to Health/Care Consumers in 2025: The 2025 Health Populi TrendCast
At this year-end time each year, my gift to Health Populi readers is an annual “TrendCast,” weaving together key data and stories at the convergence of people, health care, and technology with a look into the next 1-3 years. If you don’t know my work and “me,” my lens is through health economics broadly defined: I use a slash mark between “health” and “care” because of this orientation, which goes well beyond traditional measurement of how health care spending is included in a nation’s gross domestic product (GDP); I consider health across the many dimensions important to people, addressing physical,
What Stays True for U.S. Health Care Post #Election2024 (1) – Consumers’ Dissatisfaction with Drug Prices
For health care, there are many uncertainties as we reflect, one week after the 2024 U.S. elections, on probably policy and market impacts that we can expect in 2025 and beyond. In today’s Health Populi post, I’ll reflect on the first of several certainties we-know-we-know about U.S. health citizens and key factors shaping the American health ecosystem. In this first of several posts on “What Stays True for U.S. Health Care Post #Election2024,” I’ll focus on U.S. consumer dissatisfaction with drug prices — across political party identification. Let’s set the context with data from a recently-published
“People will seek wellness, peace and healing” – Reading the GWI Future of Wellness Report, 2024 Trends
Healthy eating and weight loss, personal care and beauty, exercise and physical activity, and wellness tourism are the four biggest components of the world’s wellness economy, quantified in The Future of Wellness, 2024 Trends, the perennial report from the Global Wellness Institute (GWI). Here’s the bubble chart, which I’ve updated with the 2025 data so we get a sense of what the coming year will bring for the eleven total segments that make up the global wellness market. The fine print of the projections for these areas identifies the annual growth rates for
The Smart Home for Health, Brought to You by Samsung and Ashley
Today I am keynoting the OSF Digital Health Symposium in Peoria, IL, discussing The State(s) of Digital Health. A double-entendre intended, one of the states I’ll be discussing is the migration of acute care back to peoples’ homes, embedded with sensors, householders donning smart rings, and rooms fitted with Internet-of-Things for health and well-being. In this context, news that Samsung has begun to partner with Ashley, the national furniture dealer, struck me as interesting and important. I visited the Samsung Health House at CES 2024 last January: here is my write-up about what I
Peoples’ Lack of Trust in Science Extends to Views on Food and Nutrition
Only 2 in 5 people in the U.S. strongly trust science concerning food, nutrition, or diet, we learn from the 2024 IFIC Spotlight Survey: Americans’ Trust in Food & Nutrition Science, published in October. IFIC is the International Food Information Council, a non-profit organization with a mission of communicating science-based information about food safety, nutrition, and sustainable food systems. IFIC surveyed 1,000 U.S. adults online in July to gauge consumers’ views on food and science. The most-trusted sources of food information are the scientists involved in researching nutrition,
Americans’ Perspectives on Pharma and Healthcare Industries Are Low and Low-Ish Compared with Most Other Sectors
Only 20% of U.S. adults have a positive view of the pharmaceutical industry, garnering the lowest positive vibes among Americans in Gallup’s latest survey on peoples’ opinions of industries in America. About 1 in 3 Americans feel positively about health care in the U.S., on par with publishing and the electric/gas industries — on the lower end of these findings. By far, the top-perceived industry in the U.S. is agriculture and farming, taking the first spot with 64% of Americans’ positive views. Restaurants and the computer sector get 52% positives, although Gallup points out
Obesity is a Public Health Epidemic in the U.S. — The Case for GLP-1 Coverage, Affordability and Equity
“If the U.S. were sensible, weight management would be treated as a public health issue,” David Cutler writes in the JAMA Health Forum dated August 15, 2024. Dr. Cutler, distinguished economics professor at Harvard, talks about “the pathology of U.S. health care” citing the example of weight loss medications — in short, the uptake of GLP-1 drugs to address Type 2 diabetes first, and subsequently obesity. Dr. Cutler notes that the price of these drugs in the U.S. “far exceeds” that of other countries: specifically, 9 times that of the prices in Germany and the Netherlands
The New DTC Channel Is…A Vending Machine (From Advil to Plan B)
I’m off to Florence, Italy, soon, where about 10 years ago I happened upon a vending machine sited outside of a pharmacy just a few blocks from the Duomo — the Farmacia Della Condotta. And in that vending machine, accessible at all hours (especially overnight when the pharmacy was closed), were all manners of direct-to-consumer self-care goods….including condoms. What distinguished this from other vending machines that might have channeled condoms at the time was that those tended to be located in men’s rooms in, say, bars — not openly on a city street. You can see the Italian vending machine
Consumers Demand Foods That Are Healthy AND Delicious – and Some Health Equity Implications
The most common food-eating styles practiced by U.S. consumers are low sugar/diabetic diets, low-calorie, dairy-free, anti-inflammatory, and gluten-free, ccording to the Midyear Trends update from Datassential. In their update on the food trends entering the second half of 2024, Datassential offered several insights on consumers and food-as-medicine in a section called the Health Check-Up. These trends are shaping consumers’ food demands in both their grocery shopping preferences (for food consumed in the home) as well as their eating-out ordering strategies — where 35% of consumers want to see menu offerings with foods that are
The Cost of GLP-1 Drugs on Payers’ Minds as Nearly 1/3rd of U.S. Consumers Could Become Users
With 70 different clinical trials for GLP-1 drugs in process with the FDA, payers — and other stakeholders in the health care ecosystem — have the semaglutide-SENSE top of mind, based on my ongoing updating of this fast-moving market space. For overall market context on pace-of-growth in adoption, check out this chart from a JAMA Health Forum research letter on Prescription Fills for Semaglutide Products by Payment Method, published August 2nd. The study was based on the IQVIA National Prescription Audit PayerTrak data which captures 92% of Rx’s filled at retail pharmacies in
Will the Apple Watch, Samsung Galaxy or Oura Rings Become “Intelligent Guardians” For Health?
One of the few bright spots in consumer technology spending in the past couple of years of the U.S. economic “vibecession” has been the category of smartwatches. The Wall Street Journal recently talked, specifically, about the growing role of the Apple Watch for health care, gaining traction as a part of cardiologists’ and other physicians’ testing for and adoption of the wearable tech device for patients who are managing medical conditions. Data from CTA, the Consumer Technology Association, has been tracking such spending which I’ve often discussed here in Health Populi
Most Americans Follow an Eating Pattern in Search of Energy, Protein, and Well-Being – With Growing Financial Stress: A Food as Medicine Update
Most Americans follow some kind of eating regime, seeking energy, more protein, and healthy aging, according to the annual 2024 Food & Health Survey published this week by the International Food Information Council (IFIC). But a person’s household finances play a direct role in their ability to balance healthful food purchases and healthy eating, IFIC learned. In this 19th annual fielding of this research, IFIC explored 3,000 U.S. consumers’ perspectives on diet and nutrition, trusted sources for food information, and new insights into peoples’ views on the GLP-1 weight-loss drugs and the growing sense